Professor Chng Wee Joo is Vice President (Biomedical Sciences Research) at the National University of Singapore. In this role, he spearheads the development of the University’s biomedical-related research, as well as strategic collaborations with academic institutes, hospitals and industrial partners. Prof Chng is also the Yong Loo Lin Professor in Medical Oncology, Group Director of Research at the National University Health System, and the inaugural Executive Director of the Singapore Translational Cancer Consortium.

A hematologist by training, Prof Chng is an esteemed researcher in the fields of genomics, therapeutics and hematologic malignancies, with a wealth of experience spanning clinical practice, administration, and leadership. He has produced highly translational research, including using global genomic techniques to understand drug resistance and improve disease prognosis in hematological malignancies — that has helped to personalise treatment and improve patient outcomes. Prof Chng’s impactful research has won him numerous national and global accolades, including the International Myeloma Foundation’s Brian G.M. Durie Outstanding Achievement Award in 2020 — becoming the first in Asia to achieve this honour — and the National Medical Research Council’s National Outstanding Clinician Scientist Award in 2016.

Prof Chng has been a Senior Consultant at the National University Hospital for over two decades, and was Vice Dean of Research at the Yong Loo Lin School of Medicine (2022 – 2023), Director of the National University Cancer Institute, Singapore (2014– 2023), and Provost’s Chair (2018 – 2022). He is also a member of numerous leading national and international professional committees, including the American Association of Cancer Research, and was former President of the Singapore Society of Hematology.

Prof Chng obtained his medical degree from the University of Leeds, and completed his internal medicine residency and fellowship training in hematology in the United Kingdom and Singapore respectively.